Use of cardiac radiation therapy as bridging therapy to CAR‐T for relapsed pediatric B‐cell acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

Use of cardiac radiation therapy as bridging therapy to CAR‐T for relapsed pediatric B‐cell acute lymphoblastic leukemia

Published:2020-12-23 Issue:3 Volume:68 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Marquez Cesar P.¹²,Montiel‐Esparza Raul³,Hui Caressa²,Schultz Liora M.³,Davis Kara L.³,Hoppe Richard T.²,Donaldson Sarah S.²^ORCID,Ramakrishna Sneha³,Hiniker Susan M.²^ORCID

Affiliation:

1. School of Medicine Stanford University Stanford California

2. Department of Radiation Oncology Stanford University Stanford California

3. Department of Pediatrics Bass Center for Childhood Cancer and Blood Disorders Center for Cancer Cell Therapy Stanford University Stanford California

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.28870

Reference24 articles.

1. Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia

2. Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults

3. T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial

4. Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia

5. Mechanisms of resistance to CAR T cell therapy

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges and strategies associated with CAR-T cell therapy in blood malignancies;Experimental Hematology & Oncology;2024-02-24

2. Polo-like kinase 1 Decrease During Induction Therapy Could Indicate Good Treatment Response, Favorable Risk Stratification, and Prolonged Survival in Pediatric Acute Lymphoblastic Leukemia: [RETRACTED];Journal of Pediatric Hematology/Oncology;2023-02-20

3. Combination strategies to optimize the efficacy of chimeric antigen receptor T cell therapy in haematological malignancies;Frontiers in Immunology;2022-08-23

4. Preparing for CAR T cell therapy: patient selection, bridging therapies and lymphodepletion;Nature Reviews Clinical Oncology;2022-03-22

5. Characterization of Extramedullary Disease in B-ALL and Response to CAR T-cell Therapy;Blood Advances;2021-12-17